Recital 22, Directive (EU) 1998/44

In forcesince 6 Jul 1998cited 2×

Whereas the discussion on the patentability of sequences or partial sequences of genes is controversial; whereas, according to this Directive, the granting of a patent for inventions which concern such sequences or partial sequences should be subject to the same criteria of patentability as in all other areas of technology: novelty, inventive step and industrial application; whereas the industrial application of a sequence or partial sequence must be disclosed in the patent application as filed;

  • Judgment of the Court (Grand Chamber) of 6 July 2010. Monsanto Technology LLC v Cefetra BV and Others.Decision

    Moreover, the import of recitals 22 and 24 in the preamble to, and Article 5(3) of the Directive is that a DNA sequence does not enjoy any protection under patent law when the function performed by that sequence is not specified.

    6 Jul 2010 · 62008CJ0428

  • Opinion of Mr Advocate General Mengozzi delivered on 9 March 2010. Monsanto Technology LLC v Cefetra BV and Others.Decision

    In the first place, various provisions of Directive 98/44 highlight the fact that, in order to be able to obtain a patent relating to a DNA sequence, it is necessary to specify the function performed by that sequence. I would refer in that …

    9 Mar 2010 · 62008CC0428